ContextVision AB
OSE:CONTX
Intrinsic Value
ContextVision AB operates as a medical technology software company that specializes in image analysis and artificial intelligence. [ Read More ]
The intrinsic value of one CONTX stock under the Base Case scenario is 8.61 NOK. Compared to the current market price of 5.98 NOK, ContextVision AB is Undervalued by 31%.
Valuation Backtest
ContextVision AB
Run backtest to discover the historical profit from buying and selling CONTX stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
ContextVision AB
Current Assets | 86.7m |
Cash & Short-Term Investments | 58.1m |
Receivables | 26.7m |
Other Current Assets | 1.9m |
Non-Current Assets | 16.5m |
Long-Term Investments | 926k |
PP&E | 9.2m |
Intangibles | 6.3m |
Other Non-Current Assets | 2k |
Current Liabilities | 23.4m |
Other Current Liabilities | 23.4m |
Non-Current Liabilities | 2m |
Long-Term Debt | 1.5m |
Other Non-Current Liabilities | 447k |
Earnings Waterfall
ContextVision AB
Revenue
|
132.2m
SEK
|
Cost of Revenue
|
-2.5m
SEK
|
Gross Profit
|
129.7m
SEK
|
Operating Expenses
|
-89.7m
SEK
|
Operating Income
|
40m
SEK
|
Other Expenses
|
-7.3m
SEK
|
Net Income
|
32.7m
SEK
|
Free Cash Flow Analysis
ContextVision AB
CONTX Profitability Score
Profitability Due Diligence
ContextVision AB's profitability score is 79/100. The higher the profitability score, the more profitable the company is.
Score
ContextVision AB's profitability score is 79/100. The higher the profitability score, the more profitable the company is.
CONTX Solvency Score
Solvency Due Diligence
ContextVision AB's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
ContextVision AB's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CONTX Price Targets Summary
ContextVision AB
According to Wall Street analysts, the average 1-year price target for CONTX is 6.63 NOK with a low forecast of 6.57 NOK and a high forecast of 6.83 NOK.
Shareholder Return
CONTX Price
ContextVision AB
Average Annual Return | 23.39% |
Standard Deviation of Annual Returns | 71.64% |
Max Drawdown | -79% |
Market Capitalization | 464.2m NOK |
Shares Outstanding | 77 367 504 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
ContextVision AB operates as a medical technology software company that specializes in image analysis and artificial intelligence. The company is headquartered in Stockholm, Stockholm and currently employs 53 full-time employees. The firm's products are tailored primarily for medical imaging equipment manufacturers. Its product portfolio is structured into six groups, namely Mammography, comprising such products, as GOPView MAMMO, MAMMO PLUSViev and C-CAD; Ultrasound, comprising the US PlusView family of products, GOPView USXI and GOPiCE US products; Magnetic Resonance Imagining (MRI), comprising the GOPView MRI2 product; Computer tomography (CT), comprising the GOPView CT software; Digital X-Ray, comprising such products, as GOPView XR2 and GOPView XR2-DI, among others, and Interventional Radiology/Fluoroscopy, comprising the GOPView IRV Plus and GOPView IRV Ultra products. As of December 31, 2011, the Company had one wholly owned subsidiary, ContextVision Inc, based in the United States.
Contact
IPO
Employees
Officers
The intrinsic value of one CONTX stock under the Base Case scenario is 8.61 NOK.
Compared to the current market price of 5.98 NOK, ContextVision AB is Undervalued by 31%.